AstraZeneca’s Nexium Marketing Targeted In Consumer Suit
This article was originally published in The Tan Sheet
Executive Summary
A lawsuit filed in U.S. Superior Court in Los Angeles alleges AstraZeneca employed "unfair and deceptive" practices in promoting its proton pump inhibitor Nexium (esomeprazole)